Dr Reddys launches Febuxostat in US market; stock turns positive
Dr Reddys launches Febuxostat in US market; stock turns positive

Dr Reddys launches Febuxostat in US market; stock turns positive

Anthony Fernandes Article rating: 5.0

The shares of Dr Reddy's Laboratories were trading in the green on Monday after the drug manufacturer announced the launch of Febuxostat tablets, a therapeutic equivalent generic version of Uloric (Febuxostat) tablets.    

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.3

The market opened in green on January 11, 2021, overall volumes in futures & options currently stand at 1,92,36,214 contracts with a turnover of Rs. 17,72,979.98 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.8

The market opened in green on January 11, 2021, overall volumes in futures & options currently stand at 1,92,36,214 contracts with a turnover of Rs. 17,72,979.98 crore.

KEC International climbs over 1 per cent on attaining new orders across various businesses
KEC International climbs over 1 per cent on attaining new orders across various businesses

KEC International climbs over 1 per cent on attaining new orders across various businesses

Shreya Chaware Article rating: 2.3

KEC International announced during the weekend that it has received new orders across its various businesses. The orders, which amount to up to Rs 1,024 crore in total, have been received in various segments such as transmission & distribution, railways, civil, solar, and cables.  

Himatsingka enters into partnership with Walt Disney for expanding its footprint in Europe
Himatsingka enters into partnership with Walt Disney for expanding its footprint in Europe

Himatsingka enters into partnership with Walt Disney for expanding its footprint in Europe

Ganesh V Article rating: 3.8

Himatsingka Seide Ltd today announced that it entered into a licensing agreement with the Walt Disney Company for the European region. It will give Himatsingka the rights to the design, develop, manufacture and distribute a broad range of home textile products inspired by Disney's vast archives and characters from all its franchises including Disney, Marvel, Pixar and Lucas.

RSS
First18761877187818791881188318841885Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR